The fifth Symposium on Infectious Disease in the Immunocompromised Host convened in Seattle last month. Experts and rising ...

Case report A 38 year old woman with no significant past medical history was diagnosed with Pneumocystis jiroveci (Pneumocystis carinii) pneumonia as her AIDS defining illness in April 2002. On 15 ...

Serotype 3 pneumonia was not observed to be associated with severity, critical care requirement, mortality or readmission. Interpretation Serotype 3 is the predominant serotype in adult pneumococcal ...

Cases of mycoplasma pneumoniae—walking pneumonia—are rising, the CDC warns. Here are symptoms to look out for, plus how to protect yourself, doctors say.

In a recent review, Hodson, et al. [78] assessed the benefits and harms of immunoglobulins (IgG), vaccines or interferon for preventing symptomatic CMV disease in solid organ transplant recipients ...

The result showed 185 adult patients with CMV-EOD, including 80 (43.2%) with hematologic malignancies, 55 (29.7%) post-solid organ transplantation, 31 (16.8%) receiving immunosuppressants, 16 (8.6%) ...

Results from a previous phase III trial showed that in the first 100 days after transplant, cytomegalovirus-seropositive patients who received letermovir had a greatly reduced incidence of ...

The objective was to elucidate the correlation between CMVP and immunosuppressive therapy in IBD patients, we hope this review could expand on the significance of CMV as an opportunistic pathogen and ...

For years, there has been relatively little attention paid to CMV, a common infection in newborns that can lead to hearing loss and other health problems. That's starting to change.

Cytomegalovirus (CMV) is a type of herpes virus that’s extremely common worldwide. In the United States alone, it’s estimated that between 50 and 80 percent of people have a CMV-related ...